In EOC, surgical reduction of the tumor mass followed by platinum-based chemotherapy leads to complete remission in approximately 60% of patients and to CA-125 concentration normalization in 86% of patients receiving first-line chemotherapy (39–41). This evidence concerns the gene MUC16 and neoplasm.